Tesaro, inc. (TSRO)
CashFlow / Quarterly
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Operating activities
Net loss

-137,088

-166,651

-162,816

-182,065

-25,277

-152,059

-136,725

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-90,980

-

-66,586

-60,557

-48,506

-47,935

-36,226

-37,051

-49,800

Adjustments to reconcile net loss to net cash used in operating activities:
Acquired in-process research and development

-

-

-

-

-

-

-

-

1,940

4,000

4,000

-

-

-

-

7,000

0

900

17,000

Depreciation and amortization expense

2,042

2,642

2,455

2,438

2,161

3,977

954

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization expense

-

-

-

-

-

-

-

-

-

-

733

-

210

128

99

-

-

-

-

Depreciation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

96

95

63

Stock-based compensation expense

24,758

28,409

26,128

23,501

25,016

23,508

18,401

14,391

12,918

11,685

9,461

8,404

8,129

5,461

3,920

3,145

2,898

3,102

2,538

Non-cash interest expense

3,664

3,501

3,312

3,146

2,916

2,915

2,757

2,758

2,610

2,610

2,472

2,472

2,344

2,344

2,200

-

-

-

-

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-80

Changes in operating assets and liabilities:
Accounts receivable

11,414

-8,190

-9,287

25,650

4,530

17,088

-134

-11,916

16,702

1,409

-2,561

-

-

-

-

-

-

-

-

Inventories

20,333

18,114

16,200

24,141

28,868

6,780

179

2,537

3,782

2,389

4,886

-

-

-

-

-

-

-

-

Other assets

-886

-7,474

4,731

7,799

1,465

7,605

3,345

3,219

2,439

1,456

656

956

1,547

784

352

-476

-1,321

-330

-200

Accounts payable

15,143

7,883

895

-1,728

5,838

-10,265

5,119

1,931

-10,625

1,566

4,293

2,433

-2,812

2,767

-464

1,974

1,266

494

486

Accrued expenses

11,020

5,992

-4,834

31,462

29,629

21,593

-1,847

16,268

9,122

2,583

3,923

3,435

8,836

6,529

1,277

-800

994

3,705

2,310

Deferred revenues

70

306

-230

204

-24

-24

-22

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues

-

-

-

-

-

-

-

-

145

432

-15

-

-

-

-

-

-

-

-

Other liabilities

-728

3,813

-898

3,966

906

-78

172

1,951

-679

-1,527

1,478

-1,414

1,502

-1,493

1,526

1,509

17

0

-16

Net cash used in operating activities

-129,607

-116,555

-147,632

-156,936

6,302

-134,906

-114,581

-

-

-

-

-

-

-

-

-

-

-

-

Investing activities
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-67,616

-

-50,592

-44,605

-40,300

-32,313

-29,608

-28,425

-27,139

Acquisition of product candidates, technology licenses and milestone payments

-

-

-

-

-

-

-

9,940

1,000

4,000

4,000

-

-

-

-

7,000

0

900

17,000

Purchase of property and equipment

585

1,553

1,619

1,052

617

2,519

1,790

1,075

1,230

210

380

436

926

771

172

42

24

341

604

Net cash provided by (used in) investing activities

34,415

-1,553

-1,619

-19,587

-617

-44,519

-1,790

-

-

-

-

-

-

-

-

-

-

-

-

Financing activities
Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-4,380

-

-1,926

-771

-172

-7,042

-24

-1,241

-17,604

Proceeds from sale of common stock, net of issuance costs

-

-

-

0

0

0

-8

224,186

408,944

49,997

154,972

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options and Employee Stock Purchase Plan

3,367

870

4,497

3,870

7,501

15,025

3,323

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

3,367

196,870

4,497

297,466

7,501

15,025

3,315

-

-

-

-

-

-

-

-

-

-

-

-

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

-410

-2,650

651

-

132

321

45

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of common stock, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-187

179,950

-

0

0

94,199

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

1,338

-

878

538

2,807

703

92

349

519

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

156,310

-

667

599

182,757

304

174,456

469

94,718

Decrease in cash, cash equivalents, and restricted cash

-92,235

76,112

-144,103

120,990

13,318

-164,079

-113,011

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

5,744

84,314

-

-

-

-

-

-

-

-

Increase in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-51,851

-44,777

142,285

-39,051

144,824

-29,197

49,975

Non-cash investing and financing activities
Common stock issuance costs - cash not paid as of period end

-

-

-

-

-

-

-

-

-

-

-

-

-

-

204

-

-

-

-

Stock option exercise proceeds receivable as of period end

-

-

-

-

36

-68

103

-

-

2,793

82

-

-

-

-

-

-

-

-

Leasehold improvement assets funded by lessor

-

-

-

0

0

0

585

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of property and equipment - cash not paid as of period end

-

-

56

-288

210

-183

301

-

-

-

-

-

-

-

-

-

-

-

340

Supplemental disclosure of cash flow information
Cash paid for interest

13,006

7,819

12,274

0

3,019

0

3,019

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes paid

653

188

80

105

153

139

176

-

-

-

-

-

-

-

-

-

-

-

-